Cargando…
Improved oxygenation following methylprednisolone therapy and survival in paediatric acute respiratory distress syndrome
BACKGROUND: Methylprednisolone remains a commonly used ancillary therapy for paediatric acute respiratory distress syndrome (PARDS), despite a lack of level 1 evidence to justify its use. When planning prospective trials it is useful to define response to therapy and to identify if there is differen...
Autores principales: | Mitting, Rebecca B., Ray, Samiran, Raffles, Michael, Egan, Helen, Goley, Paul, Peters, Mark, Nadel, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879165/ https://www.ncbi.nlm.nih.gov/pubmed/31770398 http://dx.doi.org/10.1371/journal.pone.0225737 |
Ejemplares similares
-
Survey of Oxygen Delivery Practices in UK Paediatric Intensive Care Units
por: Raman, Sainath, et al.
Publicado: (2016) -
Adverse reaction of methylprednisolone pulse therapy: Acute respiratory distress syndrome
por: Ashtari, Fereshteh, et al.
Publicado: (2021) -
Prolonged Methylprednisolone Therapy in the Fibro-Proliferative Phase of Acute Respiratory Distress Syndrome
por: Kocakaya, Derya, et al.
Publicado: (2021) -
Management of paediatric acute respiratory distress syndrome
por: Schneider, N., et al.
Publicado: (2022) -
The future of paediatric acute respiratory distress syndrome
por: Carlton, Erin F, et al.
Publicado: (2023)